TY - JOUR AU - Jiménez-Romero, Miguel E AU - Canelón-Castillo, Elba Y AU - Díez-Farto, Sara AU - Santotoribio, Jose D PY - 2019 DO - 10.21037/tau.2019.10.03 SN - 2223-4691 UR - http://hdl.handle.net/10668/14795 T2 - Translational andrology and urology AB - Presentation of the interesting case of a patient suffering from castrate-resistant prostate cancer (CRPC) with bone metastasis, who received concomitant treatment with abiraterone acetate (AA) and radium-223. The patient experienced significant... LA - en KW - Radium chloride Ra-223 KW - abiraterone acetate (AA) KW - bone metastasis KW - metastatic castrate-resistant prostate cancer (CRPC) KW - radiopharmaceutical TI - Radium 223 combined with new hormone therapies for the treatment of castrate-resistant metastatic prostate cancer: scientific evidence and sharing of our experience. TY - research article VL - 8 ER -